Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with a SARS-CoV-2 infection. The test can be performed in environments where the patient specimen is both collected and analyzed, such as doctor’s offices, hospitals and mobile testing…
eTurboNews članci su samo za pretplatnike. Pretplata je BESPLATNO.
Pretplatnici se prijavljuju ovdje Kliknite ovdje da se pretplatite BESPLATNO
Pretplatnici se prijavljuju ovdje Kliknite ovdje da se pretplatite BESPLATNO
ŠTO ISKLJUČITI IZ OVOG ČLANKA:
- The test can be performed in environments where the patient specimen is both collected and analyzed, such as doctor’s offices, hospitals and mobile testing….
- Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test that detects chemical compounds in breath samples associated with a SARS-CoV-2 infection.
- eTurboNews članci su samo za pretplatnike.
